First Indian company to follow global recommendations in accordance with the World Health Organisation (WHO) WHO has recommended NH 2025–26 strains – an A/Victoria/4897/2022 (H1N1)pdm09-like virus; an A/Croatia/10136RV/2023 (H3N2)-like virus; and a B/Austria/1359417/2021 (B/Victoria lineage)-like virus1. Mumbai, September 2025: Zydus Lifesciences Ltd., a global innovation led healthcare company, today announced …
Read More »Childlike, Real, and Unconventional: Supriya Shukla on Playing Maeri in Sony SAB’s Ufff…Yeh Love Hai Mushkil
Mumbai, August 2025: Sony SAB’s Ufff…Yeh Love Hai Mushkil has been striking a balance between heartwarming family moments and emotional drama, with each character adding depth to the Sinha family’s journey. Among them is Maeri, played by veteran actor Supriya Shukla, who brings a refreshing and layered portrayal of a …
Read More »I underestimated her punch!”: Rishi Saxena on Sumbul Touqeer Khan’s playful side from the sets of Sony SAB’s Itti Si Khushi
Mumbai, September 2025: Sony SAB’s Itti Si Khushi has been garnering love for its heartwarming and emotionally rich narrative. At the center of the story is Anvita (Sumbul Touqeer Khan), a 21-year-old girl who shoulders the responsibility of her family in the absence of her mother and an emotionally unavailable …
Read More »INEO and Dolphin Digital Connect Retail Media Platforms
INEO and Dolphin Digital partner to monetize dynamic digital ad displays in retail stores nationwide Surrey, British Columbia–(Newsfile Corp. – September 2, 2025) – INEO Tech Corp. (TSXV: INEO) (OTCQB: INEOF) (the “Company” or “INEO“), announces today a strategic partnership with Dolphin Digital, a Dallas-based leader in Digital Out-of-Home (DOOH) …
Read More »Elemental Altus Expands Royalty Portfolio with Cornerstone Laverton Acquisition and Dugbe Development Asset
Vancouver, British Columbia–(Newsfile Corp. – September 2, 2025) – Elemental Altus Royalties Corp. (TSXV: ELE) (OTCQX: ELEMF) (“Elemental Altus” or the “Company“) is pleased to announce the creation of a cornerstone gold royalty at Laverton in Western Australia. The Laverton royalty acquisition builds on the Company’s existing coverage to create a cornerstone gold …
Read More »8.4 Meters at 50 g/t AuEq Drilled at Great Pacific Gold’s Wild Dog Project
Vancouver, British Columbia–(Newsfile Corp. – September 2, 2025) – Great Pacific Gold Corp. (TSXV: GPAC) (OTCQX: FSXLF) (FSE: V3H) (“Great Pacific Gold,” “GPAC,” or the “Company”) announces results from its recently expanded Phase 1 diamond drill program at its flagship Wild Dog Project (“Wild Dog” or the “Project”), located on …
Read More »ONGold Initiates Infill Sampling Program to Recover Missing Tungsten and Gold Assays at Monument Bay for Enhanced Resource Modeling and Development
Toronto, Ontario–(Newsfile Corp. – September 2, 2025) – ONGold Resources Ltd. (TSXV: ONAU) (OTCQB: ONGRF) (“ONGold“) is pleased to announce that the company has initiated an infill sampling program targeting intervals not previously sampled for tungsten and gold throughout the Monument Bay deposit (“Monument Bay“) where tungsten could add a significant gold …
Read More »Medicus Pharma Ltd. Completes Acquisition of Antev Limited
Antev is developing Teverelix, a next generation GnRH Antagonist, as a first in class market product for Acute Urinary Retention (AURr) and high CV risk Prostate Cancer collecting representing ~US$6 billion in potential market opportunity Patrick J. Mahaffy, a veteran pharma executive and the former Chairman of Antev, appointed to …
Read More »Lara Signs Binding Letter of Intent for Its Itaituba Vanadium Project
Vancouver, British Columbia–(Newsfile Corp. – September 2, 2025) – Lara Exploration Ltd. (TSXV: LRA) (“Lara” or the “Company”) is pleased to report that it has signed a binding letter of intent with a non-reporting Ontario company (the “Optionee”), to fund further exploration and development of Lara’s Itaituba Vanadium Project (the “Project”), located …
Read More »Soricimed Biopharma Inc. Strengthens Executive Team with Appointment of Dr. Michael Groaning PhD, as Chief Scientific Officer
Moncton, New Brunswick and Boston, Massachusetts–(Newsfile Corp. – September 2, 2025) – Soricimed Biopharma Inc. (“Soricimed”), a clinical-stage biopharmaceutical company focused on developing precision oncology drugs, today announced the appointment of Dr. Michael Groaning PhD, as Chief Scientific Officer (CSO). This strategic addition underscores Soricimed’s commitment to advancing its TRPV6-targeting …
Read More »
Matribhumi Samachar English